ZA202202833B - Compound a1, preparation method thereof and application thereof as pranoprofen impurity - Google Patents
Compound a1, preparation method thereof and application thereof as pranoprofen impurityInfo
- Publication number
- ZA202202833B ZA202202833B ZA2022/02833A ZA202202833A ZA202202833B ZA 202202833 B ZA202202833 B ZA 202202833B ZA 2022/02833 A ZA2022/02833 A ZA 2022/02833A ZA 202202833 A ZA202202833 A ZA 202202833A ZA 202202833 B ZA202202833 B ZA 202202833B
- Authority
- ZA
- South Africa
- Prior art keywords
- pranoprofen
- impurity
- compound
- preparation
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N2030/042—Standards
- G01N2030/047—Standards external
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110494473.1A CN113214276A (en) | 2021-05-07 | 2021-05-07 | Compound A1, preparation method thereof and application thereof as pranoprofen impurity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202202833B true ZA202202833B (en) | 2022-06-29 |
Family
ID=77091340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2022/02833A ZA202202833B (en) | 2021-05-07 | 2022-03-09 | Compound a1, preparation method thereof and application thereof as pranoprofen impurity |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN113214276A (en) |
| ZA (1) | ZA202202833B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113429415B (en) * | 2021-07-28 | 2022-08-30 | 海南碧凯药业有限公司 | Preparation method of pranoprofen impurity |
| CN115677733A (en) * | 2022-12-20 | 2023-02-03 | 济南宣正药业有限公司 | Compound for pranoprofen quality research and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110655517A (en) * | 2019-07-04 | 2020-01-07 | 安徽贝克生物制药有限公司 | Preparation method of doriravir open-loop impurities and impurities thereof |
| CN110372713B (en) * | 2019-08-15 | 2022-05-17 | 广州市汉普医药有限公司 | Refining and purifying method of pranoprofen |
-
2021
- 2021-05-07 CN CN202110494473.1A patent/CN113214276A/en active Pending
-
2022
- 2022-03-09 ZA ZA2022/02833A patent/ZA202202833B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN113214276A (en) | 2021-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4204412A4 (en) | Heteroaryl compounds, preparation methods and uses thereof | |
| EP3753941A4 (en) | Pyrimidine-fused cyclic compound, preparation method therefor and application thereof | |
| EP3677583A4 (en) | Nitrogenous heterocyclic compound, preparation method, intermediate, composition, and application | |
| IL286471A (en) | Heteroaryl derivative, method for producing the same, and pharmaceutical composition comprising same as effective component | |
| ZA202202830B (en) | Compound a3 and preparation method and application as pranoprofen impurity thereof | |
| ZA202202833B (en) | Compound a1, preparation method thereof and application thereof as pranoprofen impurity | |
| EP3777894A4 (en) | Brain-targeting, long-acting protein conjugate, preparation method therefor, and composition comprising same | |
| EP3854303C0 (en) | Bio-electrode composition, bio-electrode, and method for manufacturing bio-electrode | |
| EP4249480A4 (en) | Diphenylpyrazole compound, and preparation method therefor and application thereof | |
| EP4196125A4 (en) | Compounds, compositions and methods | |
| ZA202202832B (en) | Compound a2, preparation method thereof and application thereof as pranoprofen impurity | |
| EP3819303A4 (en) | Glycoside compound and preparation method therefor, composition, application, and intermediate | |
| EP3689884A4 (en) | Novel indene-based transition metal compound, transition metal catalyst composition comprising same, and method for preparing ethylene homopolymer or copolymer of ethylene and -olefin by using same | |
| SG11202008531RA (en) | Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof | |
| EP4175642A4 (en) | Compounds, compositions and methods | |
| ZA202100827B (en) | Novel compound, preparation method and application thereof | |
| EP4065553A4 (en) | Novel compound, preparation method thereof, and use thereof | |
| EP4253553A4 (en) | Yeast mannan-oligosaccharide, preparation method therefor, and application thereof as yeast prebiotic | |
| EP4140993A4 (en) | Efficient preparation method for tedizolid intermediate, and intermediate | |
| EP4201926A4 (en) | Novel intermediate, preparation method for same, and applications thereof | |
| EP4050653A4 (en) | Method for preparing semiconductor structure, and semiconductor structure | |
| EP4082556A4 (en) | Compound preparation for neuranagenesis, and preparation method therefor and use thereof | |
| EP4206208A4 (en) | Mono-tin organic compound, preparation method therefor and use thereof | |
| EP3889165A4 (en) | Vaccine composition for preventing rabies, and preparation method therefor | |
| EP3901161A4 (en) | Cyclic dinucleotide prodrug molecule, preparation method therefor and application thereof |